Nuclear Medicine News and Research

RSS

Nuclear medicine is a branch or specialty of medicine and medical imaging that uses radioactive isotopes (radionuclides) and relies on the process of radioactive decay in the diagnosis and treatment of disease. In nuclear medicine procedures, radionuclides are combined with other chemical compounds or pharmaceuticals to form radiopharmaceuticals.

Bracco release confirms Positron's market growth prediction of cardiac PET

Positron Corporation, a leader as a molecular imaging and solutions company specializing in the field of Nuclear Cardiology, cites an article posted on AuntMinnie.com, the largest community website for medical imaging professionals, relating to the growth in cardiac PET.

19 Jun 2010

Naviscan announces presentations on PEM technology at Society of Nuclear Medicine Annual Meeting

Naviscan's Positron Emission Mammography (PEM) technology was the focus of several presentations and discussions at the Society of Nuclear Medicine Annual Meeting in Salt Lake City. The focus represents a growing interest and validation of how PEM can play an important role in the fight against breast cancer.

18 Jun 2010

Molecular imaging fusion with CT anatomy results in precise localization of parathyroid lesions: Research

SNM's 2010 Image of the Year illustrates the potential of hybrid molecular imaging to provide precise information about the location and function of a condition known as "hyperparathyroidism." Researchers selected this image from more than 1,500 studies presented over the course of four days during SNM's 57th Annual Meeting in Salt Lake City.

16 Jun 2010

New computer program allows early diagnosis of Alzheimer's disease

Researchers of the University of Granada have developed a new computer program that allows early diagnosis of Alzheimer's disease through processed images.

11 Jun 2010

Researchers develop new computer program for early diagnosis of Alzheimer's disease

Researchers of the University of Granada have developed a new computer program that allows early diagnosis of Alzheimer's disease through processed images. This new system has enhanced successful early diagnosis of Alzheimer's disease up to 90%, which is an important progress within this area of study.

10 Jun 2010

Spectrum Dynamics commences ultra low dose trials of radiopharmaceutical agents with D-SPECT technology

Cardiovascular imaging accounts for 30 percent of all the radiation patients receive in the U.S. and today, at the Society for Nuclear Medicine annual meeting, Spectrum Dynamics announced it has begun clinical studies to show that its D-SPECT™ technology can accommodate significantly lower doses of radiopharmaceutical agents so the total radiation exposure to patients and staff is much lower compared to conventional cardiac imaging.

10 Jun 2010

Lantheus presents preliminary Phase 2 data of flurpiridaz F18 injection PET MPI at 57th SNM

Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced preliminary Phase 2 data describing the methodology used to define an imaging protocol for a one-day rest-stress myocardial perfusion imaging test using its novel investigational PET imaging agent flurpiridaz F 18 injection (formerly known as BMS747158).

10 Jun 2010

TF2 bispecific antibody pretargeted therapy prolongs survival in animal model of human colonic cancer

Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that pretargeted therapy with TF2, a bispecific antibody against carcinoembryonic antigen (CEA) and a small peptide, delayed tumor growth and prolonged survival in an animal model of human colonic cancer.

10 Jun 2010

GE Healthcare presents interim phase 2 study results of fluciclatide

GE Healthcare, a unit of the General Electric Company, today presented interim phase 2 study results of fluciclatide, in collaboration with the National Cancer Institute, a federal research agency and part of the National Institutes of Health. Fluciclatide is an integrin-targeted radiopharmaceutical under development for oncology PET imaging.

10 Jun 2010

PulmoBind product candidate has potential for early diagnosis of PH in pediatric population

Pulmo BioTech Inc. has announced that early indications are that its PulmoBind product candidate has the potential for early diagnosis of Pulmonary Hypertension in the pediatric population. PH is a potentially life threatening and crippling disease; it is also very hard to diagnose.

9 Jun 2010

GE Healthcare to present anti-[18F]FACBC phase 1 study results at Society of Nuclear Medicine annual meeting

GE Healthcare, a unit of the General Electric Company, today will present results of a phase 1 study of anti-[18F]FACBC at the 57th annual meeting of the Society of Nuclear Medicine in Salt Lake City, Utah. The presentation closely follows the launch of the phase 2 clinical development program for anti-[18F]FACBC, which was initially discovered and developed by Emory University, Atlanta, Georgia, and was licensed to Nihon Medi-Physics Co., Ltd. (NMP) of Japan.

9 Jun 2010

PET imaging with flurpiridaz F 18 better than technetium-99m sestamibi SPECT for CAD detection

Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced preliminary data from a single site participating in the multicenter Phase 2 clinical trial that showed that Positron Emission Tomography (PET) imaging with its novel investigational agent flurpiridaz F 18 injection (formerly known as BMS747158) provided better image quality than technetium-99m sestamibi single photon emission computed tomography (SPECT), the current standard for the non-invasive detection of coronary artery disease (CAD).

8 Jun 2010

GE Healthcare highlights molecular imaging technologies to help clinicians improve patient experiences

Focusing on helping clinicians improve experiences for their patients, GE Healthcare is highlighting an innovative portfolio of molecular imaging technologies and agents at the 57th annual meeting of the Society of Nuclear Medicine, June 5-9, in Salt Lake City.

7 Jun 2010

New molecular imaging agent improves diagnosis of recurrent prostate cancer

Findings of a clinical trial reported at SNM's 57th Annual Meeting indicate that a new molecular imaging agent could improve diagnosis of recurrent prostate cancer and determine the best possible course of treatment for patients.

7 Jun 2010

PET and CT colonography combination may provide suitable alternative for detecting polyps: Study

A study published in the June issue of The Journal of Nuclear Medicine shows that positron emission tomography -a molecular imaging technique-combined with computer tomography colonography may provide a suitable alternative for detecting polyps and cancer in the colon. This particular imaging method may be especially desirable for patients because it does not require sedation or bowel preparation.

2 Jun 2010

ACR Task Force proposes steps to improve relationships between radiologists and health care systems

The American College of Radiology's Task Force on Relationships between Radiology Groups and Hospitals and Other Healthcare Organizations has proposed several steps that can help improve relationships between radiologists and the health care systems that they service, according to an article in the June issue of the Journal of the American College of Radiology.

1 Jun 2010

Greater physician involvement leads to fewer low-yield exams

A new rule preventing medical support staff from completing orders for outpatient imaging exams that were likely to be negative resulted in a marked decrease in low-yield exams for patients, according to a study appearing in the June issue of Radiology.

27 May 2010

ICON announces acquisition of Timaq Medical Imaging

ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has acquired Timaq Medical Imaging, a leading European provider of advanced imaging services to pharmaceutical and biotech firms.

24 May 2010

Lantheus Medical Imaging receives additional supply of Mo-99 for production of vital medical isotopes

Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced that it has received additional supply of molybdenum-99 (Mo-99) to produce vital medical isotopes for its TechneLite® (Technetium Tc99m Generator) generators as the result of a recent agreement between the Institute for Radioelements (IRE), Fleurus, Belgium, and the Nuclear Research Institute (NRI), Rez, Czech Republic.

21 May 2010

DMS Health Technologies receives Omega's 2009 NorthFace ScoreBoard Award

DMS Health Technologies announces that it was honored for delivering 'world-class' customer service as a recipient of Omega's 2009 NorthFace ScoreBoard Award for the second consecutive year at the SCORE Conference 2010 on April 29. As rated by its own customers, DMS Health Technologies achieved excellence in customer satisfaction during the prior calendar year for mobile MRI, CT, PET/CT, nuclear medicine, digital mammography, cardiac/angio and bone densitometry services and interim solution rentals; and diagnostic imaging equipment service.

20 May 2010

Nuclear Medicine News and Research

Further Reading

Bracco release confirms Positron's market growth prediction of cardiac PET

Naviscan announces presentations on PEM technology at Society of Nuclear Medicine Annual Meeting

Molecular imaging fusion with CT anatomy results in precise localization of parathyroid lesions: Research

New computer program allows early diagnosis of Alzheimer's disease

Researchers develop new computer program for early diagnosis of Alzheimer's disease

Spectrum Dynamics commences ultra low dose trials of radiopharmaceutical agents with D-SPECT technology

Lantheus presents preliminary Phase 2 data of flurpiridaz F18 injection PET MPI at 57th SNM

TF2 bispecific antibody pretargeted therapy prolongs survival in animal model of human colonic cancer

GE Healthcare presents interim phase 2 study results of fluciclatide

PulmoBind product candidate has potential for early diagnosis of PH in pediatric population

GE Healthcare to present anti-[18F]FACBC phase 1 study results at Society of Nuclear Medicine annual meeting

PET imaging with flurpiridaz F 18 better than technetium-99m sestamibi SPECT for CAD detection

GE Healthcare highlights molecular imaging technologies to help clinicians improve patient experiences

New molecular imaging agent improves diagnosis of recurrent prostate cancer

PET and CT colonography combination may provide suitable alternative for detecting polyps: Study

ACR Task Force proposes steps to improve relationships between radiologists and health care systems

Greater physician involvement leads to fewer low-yield exams

ICON announces acquisition of Timaq Medical Imaging

Lantheus Medical Imaging receives additional supply of Mo-99 for production of vital medical isotopes

DMS Health Technologies receives Omega's 2009 NorthFace ScoreBoard Award

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News